Stanford University

Showing 5,411-5,420 of 12,906 Results

• 

  Andreas Kerschbaumer

  Postdoctoral Scholar, Immunology and Rheumatology
  

  BioDr. Andreas Kerschbaumer is a postdoctoral scholar in the Division of Immunology and Rheumatology at Stanford University, conducting research in the Robinson and Khatri Labs. His work integrates clinical rheumatology with computational and systems immunology, applying meta-analytic techniques on transcriptomic datasets to uncover mechanisms of autoimmunity and improve therapeutic strategies in rheumatology.
  
  He trained in internal medicine and rheumatology at the Medical University of Vienna, Department of Medicine III, Division of Rheumatology, where he also completed his PhD under Professors Smolen and Aletaha on treatment outcomes in inflammatory arthritis, followed by his habilitation on strategies to optimize the interpretation of clinical trial data in rheumatoid and psoriatic arthritis.
  
  Dr. Kerschbaumer has been actively engaged with the European Alliance of Associations for Rheumatology (EULAR), contributing as Fellow, Methodologist, and Co-Methodologist to multiple international taskforces, including the 2019, 2022, and 2025 rheumatoid arthritis recommendations and the 2019 and 2023 psoriatic arthritis recommendations. He is currently a member of the EULAR Quality of Care Committee and serves as Co-Abstract Chair of the ACR Rheumatoid Arthritis abstract committee.

  • Contact Info

    Mail Code: 5151

    akersch@stanford.edu
• Nina Maria Kerschbaumer

  Postdoctoral Scholar, Radiology
  
• 

  Christine Kesekwa

  Research Administrator 2, CVMed Administration
  
• Amid Keshavarzi

  Clinical Assistant Professor (Affiliated), Surgery - General Surgery
  
• 

  Daniel Kessel

  Casual - Non-Exempt, Anesthesia - Adult Pain Medicine
  

  • Contact Info

    Mail Code: 5596

    dkessel@stanford.edu
• 

  Andrew Kesselman

  Clinical Associate Professor, Radiology
  

  Current Research and Scholarly InterestsCurrently studying the role of interventional therapies in caval filtration, venous thromboembolism and primary and metastatic hepatic malignancies.

  • Contact Info

    Mail Code: 5105

    ajk266@stanford.edu
• Daniel Kessler

  Professor of Law, Keith and Jan Hurlbut Senior Fellow at the Hoover Institution, Professor of Political Economics at the GSB, Senior Fellow at the Stanford Institute for Economic Policy Research and Professor, by courtesy, of Health Policy
  

  • Contact Info

    Mail Code: 6010

    fkessler@stanford.edu
• 

  Jeffrey Ketchersid

  Clinical Assistant Professor, Medicine
  

  • Contact Info

    Mail Code: 5475

    jketch@stanford.edu
• 

  Melanie Keung

  Masters Student in Translational Research and Applied Medicine, admitted Autumn 2025
  

  • Contact Info

    mkeung@stanford.edu
• 

  Kian Keyashian

  Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
  

  BioThe management of inflammatory bowel disease continues to evolve, with the introduction of biologic and small molecule therapies and new goals of treatment, with an emphasis on healing the bowel. My career goal since my graduation from IBD fellowship in 2012 has been to improve the outcomes and quality of life of patients with inflammatory bowel disease. In line with these goals, my research has focused investigating new noninvasive diagnostic test, finding factors early in the disease course that might predict a more aggressive disease course and need for different therapies, and investigating new promising effective medications with less side effects.

  • Contact Info

    Mail Code: 6341